New scan aims to spot hidden breast cancer spread

NCT ID NCT07020806

Summary

This study is testing a new imaging agent called [68Ga]Ga DOTA-5G to see if it can better detect where metastatic lobular breast cancer has spread in the body. Researchers will enroll 30 patients to compare this new PET/CT scan against the standard FDG PET/CT scan. The main goals are to see if the new scan finds more cancer spots and if it is safe for patients.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for METASTATIC LOBULAR BREAST CARCINOMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • University of California Davis

    RECRUITING

    Sacramento, California, 95817, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

Conditions

Explore the condition pages connected to this study.